GGHC
ICPT

Gilder Gagnon Howe & Co’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,328
Closed -$657K – 297
2015
Q1 		$657K Sell
2,328
-32,709
-93% -$7.08M 0.01% 216
2014
Q4 		$5.47M Sell
35,037
-117,407
-77% -$21.7M 0.08% 135
2014
Q3 		$36.1M Buy
152,444
+7,147
+5% +$1.82M 0.52% 54
2014
Q2 		$34.4M Sell
145,297
-2,759
-2% -$727K 0.46% 56
2014
Q1 		$48.8M Buy
+148,056
New +$50M 0.67% 49

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Gilder Gagnon Howe & Co's ICPT Position: Q2 2015 in Review

Gilder Gagnon Howe & Co sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2015, closing a stake of 2,328 shares — an estimated $657K sold.

Gilder Gagnon Howe & Co first reported a position in ICPT in Q1 2014 and held it in 5 quarters. The position peaked at $48.8M in Q1 2014. 191 funds tracked by Wall St. Rank hold ICPT as of Q2 2015.

  • Gilder Gagnon Howe & Co reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 2,328 Intercept Pharmaceuticals, Inc. shares in Q2 2015, an estimated $657K.
  • Gilder Gagnon Howe & Co first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 5 quarters.
  • Gilder Gagnon Howe & Co's Intercept Pharmaceuticals, Inc. position peaked at $48.8M in Q1 2014.
  • 191 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2015.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2015, filed 30 Jul 2015.